Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial.
J Clin Oncol
; 41(4): 816-825, 2023 02 01.
Article
in En
| MEDLINE
| ID: mdl-36379002
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Adenocarcinoma
Limits:
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2023
Document type:
Article
Affiliation country: